Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment actual clinical experience data from single center.

CANDER S., ÇALAPKULU M., ÖZ GÜL Ö., ERSOY C.

20th European Congress of Endocrinology. Barcelona, Spain., 19 - 22 Mayıs 2018

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Doi Numarası: 10.1530/endoabs.56.p491
  • Bursa Uludağ Üniversitesi Adresli: Evet